Literature DB >> 3354467

Propafenone for prevention of recurrent atrial fibrillation.

C R Kerr1, G J Klein, J E Axelson, J C Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3354467     DOI： 10.1016/0002-9149(88)90373-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

Review 1.  Atrial fibrillation. The therapeutic options.

Authors:  R V Lewis
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  The drug treatment of atrial fibrillation.

Authors:  K S Channer
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

3.  Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.

Authors:  Serkan Cay; Meryem Kara; Firat Ozcan; Ozcan Ozeke; Tolga Aksu; Dursun Aras; Serkan Topaloglu
Journal:  J Interv Card Electrophysiol       Date:  2022-04-02       Impact factor: 1.900

Review 4.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

5.  Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.

Authors:  H J Crijns; A T Gosselink; K I Lie
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

Review 6.  Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.

Authors:  A Capucci; G Boriani
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

7.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.